- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05120739
Efficacy of CHX Cloths Versus CHX Soaps for Bathes Before Orthopedic Surgery (POL)
January 18, 2024 updated by: University Hospital, Grenoble
Skin Preparation of Patients Before Orthopedic Surgery : A Randomized Controlled Study on the Efficacy of Chlorhexidine Cloths Versus Chlorhexidine Soaps
Surgical site infections (SSI) in orthopedic surgery are rare events but associated with great morbidity as well as a significant additional cost.
The World Health Organization (WHO) recently carried out meta-analyzes on all the existing prophylactic measures and could not rule on the use of chlorhexidine (CHX) cloths due to the low number of studies available.
CHX cloths could actually benefit patients for whom preoperative showering is not possible, whether in emergency or trauma settings due to pain-induced functional impotence.
A randomized controlled clinical study aimed at evaluating the in vivo microbiological efficacy of CHX cloths in a population of orthopedic surgery patients while evaluating the psycho-social determinants of adherence to a new preoperative preparation technique seems essential.
Study Overview
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Grenoble, France, 38700
- CHU de Grenoble Alpes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- adult patients,
- undergoing orthopedic surgery: programmed hip prosthesis (non-urgent),
- admitted the day before the operation
- and having given their written consent.
Exclusion Criteria:
- presence of a documented infection at the time of the intervention,
- presence of skin wounds,
- presence of antibiotic treatment within 15 days before the operation
- intolerance to CHX,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional
Skin preparations (the day before and the morning of the operation) with the 2% CHX cloths
|
skin preparation in 2% CHX cloths
|
|
No Intervention: Control
Skin preparations (the day before and the morning of the operation) with the 4% CHX soap (standard of care)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative decrease in the number of bacterial colonies before the antiseptic preparation of the operating site at the surgical room (T1)
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the Grenoble Alps University Hospital (CHU GA) (T0) and after 2 preoperative skin preparations (the day before and the morning of the operation), and just before the antiseptic preparation of the operating site at the surgical room (T1) in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative decrease in the number of bacterial colonies after 1 preoperative skin preparation
Time Frame: Between the patient's admission to the CHU GA and after 1 preoperative skin preparation (Day 0)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 1 preoperative skin preparation (the day before the evening of the operation)
|
Between the patient's admission to the CHU GA and after 1 preoperative skin preparation (Day 0)
|
|
Relative decrease in the number of bacterial colonies after 2 preoperative skin preparations
Time Frame: Between the patient's admission to the CHU GA and after 2 preoperative skin preparations (Day 1)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 2 preoperative skin preparations (the night before and the morning of the operation)
|
Between the patient's admission to the CHU GA and after 2 preoperative skin preparations (Day 1)
|
|
Significant predictors of a decrease in bacterial colonization
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Significant predictors of a decrease in bacterial colonization among the sex, age of the patients, their co-morbidities, the use of cloths and the time between the last preoperative skin preparation and the skin sample in the operating room
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Percentage of skin adverse reactions
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Percentage of skin adverse reactions after 2 preoperative skin preparations in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Nursing load
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Nursing load in the 2% CHX cloths group versus 4% CHX soap group according to the Soins Infirmiers Individualisés à la Personne Soignée (SIIPS) scale
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Duration of preoperative skin preparation
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Duration of preoperative skin preparation in minutes in the 2% CHX cloths group versus 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Responses to a questionnaire for patients and adherence score
Time Frame: Between surgery and discharge from the hospital (Day 4)
|
Responses to a questionnaire for patients and adherence score in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between surgery and discharge from the hospital (Day 4)
|
|
Responses to a semi-structured interview intended for healthcare professionals
Time Frame: Interview at the end of the inclusion of patients (through study completion, an average of 6 months)
|
Responses to a semi-structured interview intended for healthcare professionals who cared for patients randomized to the 2% CHX cloths group versus the 4% CHX soap group.
|
Interview at the end of the inclusion of patients (through study completion, an average of 6 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2021
Primary Completion (Actual)
May 30, 2023
Study Completion (Actual)
May 30, 2023
Study Registration Dates
First Submitted
October 26, 2021
First Submitted That Met QC Criteria
November 3, 2021
First Posted (Actual)
November 15, 2021
Study Record Updates
Last Update Posted (Estimated)
January 19, 2024
Last Update Submitted That Met QC Criteria
January 18, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 38RC19.254
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopedic Surgery
-
Rigshospitalet, DenmarkThe Danish Medical Research Council; Oberstinde Kirsten Jensa la Cours FoundationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedOrthopedic SurgeryFrance
-
Yonsei UniversityUnknownOrthopedic Surgery-lower Leg SurgeryKorea, Republic of
-
University Hospital, LimogesCompleted
-
University Hospital, MontpellierCompleted
-
Groupe Hospitalier Paris Saint JosephWithdrawn
-
University Hospital, MontpellierUnknownOrthopedic SurgeryFrance
-
Yonsei UniversityRecruitingOrthopedic SurgeryKorea, Republic of
-
Muhammad Aamir LatifCompleted
-
University of Witten/HerdeckeGerman Research FoundationUnknownOrthopedic SurgeryGermany
Clinical Trials on 2% CHX cloths
-
Medline IndustriesCompletedCatheter-Associated Urinary Tract InfectionUnited States
-
Henry M. Jackson Foundation for the Advancement...Uniformed Services University of the Health SciencesCompletedStaphylococcus Aureus | Staphylococcal Skin Infections | Community-acquired InfectionsUnited States
-
Vanderbilt UniversitySage Products, Inc.CompletedSurgical Site Infections | Post Operative ComplicationUnited States
-
Betsie van GaalZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Ain Shams UniversityCompleted
-
Destiny Pharma PlcCompletedStaphylococcus Aureus InfectionUnited Kingdom
-
University of UtahCompleted
-
University of RochesterSage Products, Inc.Completed
-
Bezmialem Vakif UniversityCompletedPostoperative Pain | Apical PeriodontitisTurkey (Türkiye)
-
University of Santiago de CompostelaLacer, S.A.CompletedHealthy | Saliva | BiofilmsSpain